This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from January to April 2020.
The UK is in a position to lead the world into a new age of technological advances, from gene-editing therapies that could permanently cure disease to genetically modified bacteria that could rid the world of plastic waste. The Government’s focus on R&D and the life sciences sector can deliver these public benefits and build a self-sustaining innovation-based economy by harnessing our competitive advantages with smart policy decisions in the upcoming Budget.
The UK BioIndustry Association (BIA) has welcomed today’s publication of the Life Sciences 2030 Skills Strategy . The report is a key deliverable from the Life Sciences Sector Deal 2 and sets out how the UK Life Sciences sector will attract, retain, train and develop the research, manufacturing and technical skills required by a dynamic and diverse UK sector.
This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from October 2019 to January 2020.
New figures published today (Wednesday 22 January 2020) by the UK BioIndustry Association (BIA) and Informa Pharma Intelligence reveal that the UK biotech sector raised £1.3 billion in 2019.
The BIA has submitted views to the IPReg consultation on remooving restrictions on in-house patent attorneys providing pro bono advice.
This updated interim report sets out how the UK life sciences sector is driving investment and growth and makes the case for increased cost-effective public investment in the sector.